BioCentury | Apr 29, 2020
Emerging Company Profile

Bugworks: breaking the U.S.-centric antimicrobial mold

...million Investors: University of Tokyo Edge Capital, Global Brain Corp., Acquipharma Holdings, 3One4 Capital and Baxter...
BioCentury | Mar 19, 2020
Emerging Company Profile

OncoOne: targeting oxidized MIF for solid tumors

...tumor specificity.” The target was first identified as a tumor antigen by a team of Baxter International Inc....
...it through Phase I testing before it was discontinued when the company’s pipeline was acquired. Baxter...
BioCentury | Dec 4, 2019
Company News

Management tracks: Mittal to succeed Biocon’s Chandavarkar; plus Intercept, Nektar, Agios, Accelerate, ABPI and more

...as CFO of EryDel S.p.A., Egalet Corp., Strategic Diagnostics Inc. and Prism Pharmaceuticals Inc., which Baxter International Inc....
BioCentury | Sep 13, 2019
Politics, Policy & Law

Another chance to renew the social contract

...Laboratories; Brent Saunders, chairman and CEO, Allergan plc; José (Joe) Almeida, chairman, president and CEO, Baxter International Inc....
...Companies and Institutions Mentioned Abbott Laboratories (NYSE:ABT), Abbott Park, Ill. Allergan plc (NYSE:AGN), Dublin, Ireland Baxter International Inc....
...NASDAQ:OVID), New York, N.Y. Pfizer Inc. (NYSE:PFE), New York, N.Y. Steve Usdin, Washington Editor Abbott Laboratories AbbVie Inc. Allergan plc Baxter International Inc. Bayer...
BioCentury | Apr 12, 2019
Finance

AskBio answers investors’ call

...hemophilia company Chatham Therapeutics LLC. Pfizer acquired Bamboo in 2016. Following a 2014 deal with Baxter International Inc....
BioCentury | Nov 8, 2018
Product R&D

JLABS seeks lung cancer solutions in Shanghai

...job business development experience in Asia through prior positions at Aeras Global TB Vaccine Foundation, Baxter International Inc....
...significant opportunities for innovation. Companies and Institutions Mentioned Aeras Global TB Vaccine Foundation, Rockville, Md. Baxter International Inc....
BioCentury | Oct 18, 2018
Company News

Management tracks: Autolus, Bayer, Cambridge Allergy

...which was acquired by Bayer in June. Allergy company Cambridge Allergy Ltd. (Cambridge, U.K.) hired Baxter...
BioCentury | Sep 28, 2018
Company News

Opiant gets BARDA grant for intranasal opioid antagonist

...Drug Abuse (NIDA) to support development of OPNT003. Revex, an injectable formulation of nalmefene from Baxter International Inc....
BioCentury | Sep 20, 2018
Company News

Opiant gets BARDA grant for intranasal opioid antagonist

...Drug Abuse (NIDA) to support development of OPNT003. Revex, an injectable formulation of nalmefene from Baxter International Inc....
BioCentury | Aug 4, 2018
Finance

Functions of formulation

...Helen Torley told BioCentury that at the time of Halozyme’s first deals with Roche and Baxter International Inc....
...receptor; and oncology/immunology drug Rituxan rituximab (MabThera in the EU), which targets CD20. In 2007, Baxter...
...products, Baxter’s HyQvia and Roche’s Herceptin SC, entered the clinic in 2007 and 2008, respectively. Baxter...
Items per page:
1 - 10 of 1261
BioCentury | Apr 29, 2020
Emerging Company Profile

Bugworks: breaking the U.S.-centric antimicrobial mold

...million Investors: University of Tokyo Edge Capital, Global Brain Corp., Acquipharma Holdings, 3One4 Capital and Baxter...
BioCentury | Mar 19, 2020
Emerging Company Profile

OncoOne: targeting oxidized MIF for solid tumors

...tumor specificity.” The target was first identified as a tumor antigen by a team of Baxter International Inc....
...it through Phase I testing before it was discontinued when the company’s pipeline was acquired. Baxter...
BioCentury | Dec 4, 2019
Company News

Management tracks: Mittal to succeed Biocon’s Chandavarkar; plus Intercept, Nektar, Agios, Accelerate, ABPI and more

...as CFO of EryDel S.p.A., Egalet Corp., Strategic Diagnostics Inc. and Prism Pharmaceuticals Inc., which Baxter International Inc....
BioCentury | Sep 13, 2019
Politics, Policy & Law

Another chance to renew the social contract

...Laboratories; Brent Saunders, chairman and CEO, Allergan plc; José (Joe) Almeida, chairman, president and CEO, Baxter International Inc....
...Companies and Institutions Mentioned Abbott Laboratories (NYSE:ABT), Abbott Park, Ill. Allergan plc (NYSE:AGN), Dublin, Ireland Baxter International Inc....
...NASDAQ:OVID), New York, N.Y. Pfizer Inc. (NYSE:PFE), New York, N.Y. Steve Usdin, Washington Editor Abbott Laboratories AbbVie Inc. Allergan plc Baxter International Inc. Bayer...
BioCentury | Apr 12, 2019
Finance

AskBio answers investors’ call

...hemophilia company Chatham Therapeutics LLC. Pfizer acquired Bamboo in 2016. Following a 2014 deal with Baxter International Inc....
BioCentury | Nov 8, 2018
Product R&D

JLABS seeks lung cancer solutions in Shanghai

...job business development experience in Asia through prior positions at Aeras Global TB Vaccine Foundation, Baxter International Inc....
...significant opportunities for innovation. Companies and Institutions Mentioned Aeras Global TB Vaccine Foundation, Rockville, Md. Baxter International Inc....
BioCentury | Oct 18, 2018
Company News

Management tracks: Autolus, Bayer, Cambridge Allergy

...which was acquired by Bayer in June. Allergy company Cambridge Allergy Ltd. (Cambridge, U.K.) hired Baxter...
BioCentury | Sep 28, 2018
Company News

Opiant gets BARDA grant for intranasal opioid antagonist

...Drug Abuse (NIDA) to support development of OPNT003. Revex, an injectable formulation of nalmefene from Baxter International Inc....
BioCentury | Sep 20, 2018
Company News

Opiant gets BARDA grant for intranasal opioid antagonist

...Drug Abuse (NIDA) to support development of OPNT003. Revex, an injectable formulation of nalmefene from Baxter International Inc....
BioCentury | Aug 4, 2018
Finance

Functions of formulation

...Helen Torley told BioCentury that at the time of Halozyme’s first deals with Roche and Baxter International Inc....
...receptor; and oncology/immunology drug Rituxan rituximab (MabThera in the EU), which targets CD20. In 2007, Baxter...
...products, Baxter’s HyQvia and Roche’s Herceptin SC, entered the clinic in 2007 and 2008, respectively. Baxter...
Items per page:
1 - 10 of 1261